SUGALIFE-D 10/60
Composition:
Dapagliflozin 10 mg + Gliclazide 60 mg (SR)
Indication:
Used for the management of Type 2 Diabetes Mellitus in adults to help control blood sugar levels. It combines Dapagliflozin (an SGLT2 inhibitor) and Gliclazide (a sulfonylurea) for improved glycemic control when diet, exercise, and monotherapy are not sufficient.
Packing:
10X10
Pack Type:
Tab